Using gene expression profiling (GEP), a myeloid suppressive signature was identified in DLBCL peripheral blood, which consisted of an upregulated expression of MDSC-related genes, such as ARG-1, S100A12, and S100A8. The gene discussed is ARG1; the disease is diffuse large B-cell lymphoma.